FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
The article discusses the new FDA approval for the first nalmefene hydrochloride auto-injector for emergent treatment of a suspected opioid overdose.
This tool is for practices currently screening or interested in screening for diaper insecurity, a form of material hardship that negatively effects families with young children.